• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA免疫可在H-2b小鼠中诱导针对乙肝核心抗原的抗体和细胞毒性T细胞反应。

DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.

作者信息

Kuhöber A, Pudollek H P, Reifenberg K, Chisari F V, Schlicht H J, Reimann J, Schirmbeck R

机构信息

Department of Medical Microbiology, University of Ulm, Germany.

出版信息

J Immunol. 1996 May 15;156(10):3687-95.

PMID:8621903
Abstract

The serum Ab response and the class I-restricted CTL response of C57BL/6 (H-2b) mice to hepatitis B (pre)core Ag (HBcAg, HBeAg) was studied. Injection of HBcAg particles without adjuvants into mice efficiently primed serum Ab responses but not CTL response. We constructed the expression plasmids pCMV-1/c and pCMV-1/e in which expression of HBcAg or HBeAg was driven by cytomegalovirus immediate early region promoter sequences. Stable murine RBL5/C transfectant lines expressing HBcAg were established. Intramuscular DNA immunization with plasmid pCMV-1/c (encoding intracellularly expressed core Ag) or pCMV-1/e (encoding secreted precore Ag) efficiently primed specific serum Ab responses and CTL responses. The CTL response elicited in this system was mediated by CD4-CD8+ effector cells primed in vivo. The CTL recognized the HBcAg93-100 8-mer peptide MGLKFRQL in the context of Kb. Hence, DNA immunization with HBcAg/HBeAg-expressing plasmids, but not immunization with exogenous HBcAg particles, elicits a class I-restricted CTL response of defined epitope/restriction specificity in H-2b mice.

摘要

研究了C57BL/6(H-2b)小鼠对乙型肝炎(前)核心抗原(HBcAg、HBeAg)的血清抗体反应和I类限制性细胞毒性T淋巴细胞(CTL)反应。将无佐剂的HBcAg颗粒注射到小鼠体内可有效引发血清抗体反应,但不能引发CTL反应。我们构建了表达质粒pCMV-1/c和pCMV-1/e,其中HBcAg或HBeAg的表达由巨细胞病毒立即早期区域启动子序列驱动。建立了稳定表达HBcAg的鼠RBL5/C转染细胞系。用质粒pCMV-1/c(编码细胞内表达的核心抗原)或pCMV-1/e(编码分泌的前核心抗原)进行肌肉内DNA免疫可有效引发特异性血清抗体反应和CTL反应。该系统中引发的CTL反应由体内引发的CD4-CD8+效应细胞介导。CTL在Kb背景下识别HBcAg93-100 8聚体肽MGLKFRQL。因此,用表达HBcAg/HBeAg的质粒进行DNA免疫,而不是用外源性HBcAg颗粒进行免疫,可在H-2b小鼠中引发具有确定表位/限制性特异性的I类限制性CTL反应。

相似文献

1
DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.DNA免疫可在H-2b小鼠中诱导针对乙肝核心抗原的抗体和细胞毒性T细胞反应。
J Immunol. 1996 May 15;156(10):3687-95.
2
DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.用编码乙型肝炎病毒核心蛋白细胞内形式(HBcAg)或分泌形式(HBeAg)的质粒进行DNA疫苗接种,可引发T细胞对两个重叠的Kb和Kd限制性表位的反应。
Int Immunol. 1997 Aug;9(8):1203-12. doi: 10.1093/intimm/9.8.1203.
3
Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.启动针对外源性乙肝表面抗原的MHC-I限制性细胞毒性T淋巴细胞反应依赖于CD4 + T细胞。
J Immunol. 1999 Aug 15;163(4):1880-7.
4
Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.在大肠杆菌中产生具有表位的嵌合乙肝核心蛋白:病毒样颗粒的形成以及体内抗原特异性细胞毒性免疫反应和抗肿瘤作用的有效诱导剂。
Cell Immunol. 2007 May;247(1):18-27. doi: 10.1016/j.cellimm.2007.07.003. Epub 2007 Aug 20.
5
Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.兔对重组人乙型肝炎病毒核衣壳蛋白颗粒的体液免疫和细胞免疫反应的特异性
Biochemistry (Mosc). 1998 May;63(5):551-8.
6
DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.DNA疫苗接种可在排斥同基因肿瘤的H-2d小鼠中引发主要组织相容性复合体I类限制的、猿猴病毒40大肿瘤抗原特异性细胞毒性T淋巴细胞。
J Immunol. 1996 Oct 15;157(8):3550-8.
7
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.从多特异性DNA疫苗中去除免疫显性表位可诱导具有显著抗病毒潜力的CD8 T细胞。
J Immunol. 2009 Jul 1;183(1):370-80. doi: 10.4049/jimmunol.0900505.
8
Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.用可溶性乙肝病毒表面蛋白进行免疫接种可在体内引发小鼠H-2 I类分子限制的CD8 +细胞毒性T淋巴细胞反应。
J Immunol. 1994 Feb 1;152(3):1110-9.
9
Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.内质网靶向序列增强基于CTL表位的DNA疫苗诱导的HBV特异性细胞毒性T淋巴细胞。
Virology. 2005 Apr 10;334(2):255-63. doi: 10.1016/j.virol.2005.01.040.
10
[Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].[基因疫苗对小鼠乙肝病毒核心基因的体液免疫和细胞免疫原性]
Zhonghua Yi Xue Za Zhi. 1999 Jun;79(6):456-9.

引用本文的文献

1
Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8 T cell responses in naïve and persistently infected mice and protects from challenge.基于水泡病毒载体的异源初免-加强免疫方案,表达 HBV 核心抗原,可在未感染和持续性感染的小鼠中诱导 CD8 T 细胞应答,并能预防挑战感染。
Antiviral Res. 2019 Aug;168:156-167. doi: 10.1016/j.antiviral.2019.05.014. Epub 2019 May 30.
2
Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.比较在人肝癌细胞和人原代肝细胞中由重组痘苗病毒产生的乙型肝炎病毒样颗粒的纯化和表征。
PLoS One. 2019 Feb 22;14(2):e0212800. doi: 10.1371/journal.pone.0212800. eCollection 2019.
3
Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.用于慢性乙型肝炎病毒感染的基于病毒样囊泡的治疗性疫苗载体
J Virol. 2015 Oct;89(20):10407-15. doi: 10.1128/JVI.01184-15. Epub 2015 Aug 5.
4
DNA vaccines, electroporation and their applications in cancer treatment.DNA疫苗、电穿孔及其在癌症治疗中的应用。
Hum Vaccin Immunother. 2015;11(8):1889-900. doi: 10.1080/21645515.2015.1035502.
5
Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccination.治疗性DNA疫苗诱导的肝内乙型肝炎病毒特异性T细胞的功能方面
Mol Ther. 2015 Mar;23(3):578-90. doi: 10.1038/mt.2014.233. Epub 2014 Dec 10.
6
Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice.乙肝病毒核心抗原DNA疫苗的泛素缀合导致BALB/c小鼠的细胞介导免疫反应增强。
Hepat Mon. 2011 Aug;11(8):620-8. doi: 10.5812/kowsar.1735143x.689.
7
DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.用 CTLA-4 融合乙肝病毒(HBV)核心蛋白进行 DNA 免疫接种增强了 Th2 型反应,并以更快的速度清除 HBV。
PLoS One. 2011;6(7):e22524. doi: 10.1371/journal.pone.0022524. Epub 2011 Jul 22.
8
Immune-induced evolutionary selection focused on a single reading frame in overlapping hepatitis B virus proteins.免疫诱导的进化选择集中在重叠乙型肝炎病毒蛋白的单个读码框上。
J Virol. 2011 May;85(9):4558-66. doi: 10.1128/JVI.02142-10. Epub 2011 Feb 9.
9
Immune effectors required for hepatitis B virus clearance.清除乙型肝炎病毒所需的免疫效应物。
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):798-802. doi: 10.1073/pnas.0913498107. Epub 2009 Dec 22.
10
Interaction of the hepatitis B core antigen and the innate immune system.乙型肝炎核心抗原与固有免疫系统的相互作用。
J Immunol. 2009 Jun 1;182(11):6670-81. doi: 10.4049/jimmunol.0803683.